| Literature DB >> 17976801 |
Tenny J Thomas1, Denis Pauze, Jeffrey N Love.
Abstract
Lomotil (Pfizer Inc., New York, NY) (diphenoxylate-atropine) is said to be potentially toxic to toddlers with exposure to as little as one to two tablets. A review of the data on diphenoxylate-atropine poisonings from the American Association of Poison Control Centers annual reports, review articles, and case series disputes this view. Fatalities associated with diphenoxylate-atropine have been reported in toddlers after repetitive or incorrect dosages. Fortunately, trends in pediatric diphenoxylate-atropine ingestions are decreasing. We review the management, trends, and current concepts regarding pediatric diphenoxylate-atropine ingestions.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17976801 DOI: 10.1016/j.jemermed.2007.03.051
Source DB: PubMed Journal: J Emerg Med ISSN: 0736-4679 Impact factor: 1.484